By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
| Currency | US Dollars |
| Share Price | $ 122.58 |
| Change Today | $ 0.00 |
| % Change | 0.00 % |
| 52 Week High | $124.08 |
| 52 Week Low | $87.75 |
| Volume | 3,013 |
| Shares Issued | 1,246.00m |
| Market Cap | $152,735m |
| RiskGrade | 120 |
| Strong Buy | 9 |
| Buy | 12 |
| Neutral | 6 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 28 |

You are here: research